Cargando…

Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis

In multicellular organisms, cell growth and differentiation is controlled in part by programmed cell death or apoptosis. One major apoptotic pathway is triggered by Fas receptor (Fas)-Fas ligand (FasL) interaction. Neoplastic cells are frequently resistant to Fas-mediated apoptosis, evade Fas signal...

Descripción completa

Detalles Bibliográficos
Autores principales: Villamizar, Olga, Chambers, Christopher B., Riberdy, Janice M., Persons, Derek A., Wilber, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924680/
https://www.ncbi.nlm.nih.gov/pubmed/26885613
http://dx.doi.org/10.18632/oncotarget.7329
_version_ 1782439900612657152
author Villamizar, Olga
Chambers, Christopher B.
Riberdy, Janice M.
Persons, Derek A.
Wilber, Andrew
author_facet Villamizar, Olga
Chambers, Christopher B.
Riberdy, Janice M.
Persons, Derek A.
Wilber, Andrew
author_sort Villamizar, Olga
collection PubMed
description In multicellular organisms, cell growth and differentiation is controlled in part by programmed cell death or apoptosis. One major apoptotic pathway is triggered by Fas receptor (Fas)-Fas ligand (FasL) interaction. Neoplastic cells are frequently resistant to Fas-mediated apoptosis, evade Fas signals through down regulation of Fas and produce soluble Fas proteins that bind FasL thereby blocking apoptosis. Soluble Fas (sFas) is an alternative splice product of Fas pre-mRNA, commonly created by exclusion of transmembrane spanning sequences encoded within exon 6 (FasΔEx6). Long non-coding RNAs (lncRNAs) interact with other RNAs, DNA, and proteins to regulate gene expression. One lncRNA, Fas-antisense or Saf, was shown to participate in alternative splicing of Fas pre-mRNA through unknown mechanisms. We show that Saf is localized in the nucleus where it interacts with Fas receptor pre-mRNA and human splicing factor 45 (SPF45) to facilitate alternative splicing and exclusion of exon 6. The product is a soluble Fas protein that protects cells against FasL-induced apoptosis. Collectively, these studies reveal a novel mechanism to modulate this critical cell death program by an lncRNA and its protein partner.
format Online
Article
Text
id pubmed-4924680
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-49246802016-07-13 Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis Villamizar, Olga Chambers, Christopher B. Riberdy, Janice M. Persons, Derek A. Wilber, Andrew Oncotarget Research Paper In multicellular organisms, cell growth and differentiation is controlled in part by programmed cell death or apoptosis. One major apoptotic pathway is triggered by Fas receptor (Fas)-Fas ligand (FasL) interaction. Neoplastic cells are frequently resistant to Fas-mediated apoptosis, evade Fas signals through down regulation of Fas and produce soluble Fas proteins that bind FasL thereby blocking apoptosis. Soluble Fas (sFas) is an alternative splice product of Fas pre-mRNA, commonly created by exclusion of transmembrane spanning sequences encoded within exon 6 (FasΔEx6). Long non-coding RNAs (lncRNAs) interact with other RNAs, DNA, and proteins to regulate gene expression. One lncRNA, Fas-antisense or Saf, was shown to participate in alternative splicing of Fas pre-mRNA through unknown mechanisms. We show that Saf is localized in the nucleus where it interacts with Fas receptor pre-mRNA and human splicing factor 45 (SPF45) to facilitate alternative splicing and exclusion of exon 6. The product is a soluble Fas protein that protects cells against FasL-induced apoptosis. Collectively, these studies reveal a novel mechanism to modulate this critical cell death program by an lncRNA and its protein partner. Impact Journals LLC 2016-02-11 /pmc/articles/PMC4924680/ /pubmed/26885613 http://dx.doi.org/10.18632/oncotarget.7329 Text en Copyright: © 2016 Villamizar et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Villamizar, Olga
Chambers, Christopher B.
Riberdy, Janice M.
Persons, Derek A.
Wilber, Andrew
Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis
title Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis
title_full Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis
title_fullStr Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis
title_full_unstemmed Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis
title_short Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis
title_sort long noncoding rna saf and splicing factor 45 increase soluble fas and resistance to apoptosis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924680/
https://www.ncbi.nlm.nih.gov/pubmed/26885613
http://dx.doi.org/10.18632/oncotarget.7329
work_keys_str_mv AT villamizarolga longnoncodingrnasafandsplicingfactor45increasesolublefasandresistancetoapoptosis
AT chamberschristopherb longnoncodingrnasafandsplicingfactor45increasesolublefasandresistancetoapoptosis
AT riberdyjanicem longnoncodingrnasafandsplicingfactor45increasesolublefasandresistancetoapoptosis
AT personsdereka longnoncodingrnasafandsplicingfactor45increasesolublefasandresistancetoapoptosis
AT wilberandrew longnoncodingrnasafandsplicingfactor45increasesolublefasandresistancetoapoptosis